230 related articles for article (PubMed ID: 12456433)
1. Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine.
Kim KS; Lew SH; Cho HY; Cheong MA
Anesth Analg; 2002 Dec; 95(6):1656-60, table of contents. PubMed ID: 12456433
[TBL] [Abstract][Full Text] [Related]
2. Postoperative residual block after intermediate-acting neuromuscular blocking drugs.
Hayes AH; Mirakhur RK; Breslin DS; Reid JE; McCourt KC
Anaesthesia; 2001 Apr; 56(4):312-8. PubMed ID: 11284816
[TBL] [Abstract][Full Text] [Related]
3. Residual curarization in the recovery room after vecuronium.
Baillard C; Gehan G; Reboul-Marty J; Larmignat P; Samama CM; Cupa M
Br J Anaesth; 2000 Mar; 84(3):394-5. PubMed ID: 10793602
[TBL] [Abstract][Full Text] [Related]
4. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
5. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.
Debaene B; Plaud B; Dilly MP; Donati F
Anesthesiology; 2003 May; 98(5):1042-8. PubMed ID: 12717123
[TBL] [Abstract][Full Text] [Related]
6. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
[TBL] [Abstract][Full Text] [Related]
7. Postoperative muscle paralysis after rocuronium: less residual block when acceleromyography is used.
Gätke MR; Viby-Mogensen J; Rosenstock C; Jensen FS; Skovgaard LT
Acta Anaesthesiol Scand; 2002 Feb; 46(2):207-13. PubMed ID: 11942873
[TBL] [Abstract][Full Text] [Related]
8. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
Itoh H; Shibata K; Nitta S; Kobayashi T
Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
[TBL] [Abstract][Full Text] [Related]
9. The agreement between adductor pollicis mechanomyogram and first dorsal interosseous electromyogram. A pharmacodynamic study of rocuronium and vecuronium.
Engbaek J; Roed J; Hangaard N; Viby-Mogensen J
Acta Anaesthesiol Scand; 1994 Nov; 38(8):869-78. PubMed ID: 7887113
[TBL] [Abstract][Full Text] [Related]
10. Comparison of sugammadex and pyridostigmine bromide for reversal of rocuronium-induced neuromuscular blockade in short-term pediatric surgery: A prospective randomized study.
An J; Lee JH; Kim E; Woo K; Kim H; Lee D
Medicine (Baltimore); 2020 Feb; 99(7):e19130. PubMed ID: 32049831
[TBL] [Abstract][Full Text] [Related]
11. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
Mosing M; Auer U; West E; Jones RS; Hunter JM
Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
[TBL] [Abstract][Full Text] [Related]
12. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
[TBL] [Abstract][Full Text] [Related]
14. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
Kim DW; Joshi GP; White PF; Johnson ER
Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
[TBL] [Abstract][Full Text] [Related]
15. Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium.
Wierda JM; Hommes FD; Nap HJ; van den Broek L
Anaesthesia; 1995 May; 50(5):393-6. PubMed ID: 7793541
[TBL] [Abstract][Full Text] [Related]
16. Adenosine potentiation of neuromuscular blocking agents in guinea-pigs.
Nitahara K; Kornak P; Nagashima H; Vizi ES; Foldes FF; Dan K
Br J Anaesth; 2000 Feb; 84(2):245-7. PubMed ID: 10743461
[TBL] [Abstract][Full Text] [Related]
17. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
18. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
Kim KS; Chun YS; Chon SU; Suh JK
Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
[TBL] [Abstract][Full Text] [Related]
20. Onset and recovery of rocuronium (Org 9426) and vecuronium under enflurane anaesthesia.
Mayer M; Doenicke A; Hofmann A; Peter K
Br J Anaesth; 1992 Nov; 69(5):511-2. PubMed ID: 1361356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]